Monitor for any early registration or waiver of the trading restriction, which would accelerate selling pressure. Given the lockup, near-term float impact is contained, but the overhang may weigh on sentiment. The annual report (20-F filed March 2026) provides context on financial health; if fundamentals are weak, this dilution is more concerning.
Price Chart
Executive Summary
SMX amended its 2022 Incentive Equity Plan to increase authorized shares from ~671,641 to 781,641 and immediately granted 110,000 vested restricted stock units (100,000 to CEO Haggai Alon, 10,000 to a consultant). The grant represents ~10.1% dilution of the 1,088,608 outstanding shares, though registration and trading are prohibited until January 22, 2027. This is a material dilution event for a $16M market cap company.
Key Facts
- 2022 Incentive Plan authorized shares increased from approximately 671,641 to 781,641 without stockholder approval (relying on Nasdaq home-country exemption).
- 110,000 RSUs granted to CEO Haggai Alon (100,000) and a consultant (10,000); all vested upon grant.
- Underlying ordinary shares cannot be registered for trading before January 22, 2027.
- Total shares outstanding as of July 23, 2026: 1,088,608.
Financial Impact
~10.1% dilution of outstanding shares via immediate vesting RSUs, with a 6-month trading lock.
Risk Factors
- Further plan amendments or additional dilutive grants without shareholder approval.
- Weak financial performance (per recent 20-F) could amplify negative reaction to dilution.
- Potential for CEO and consultant to sell shares immediately after lockup expires.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-035025 |
| Document: 0001493152-26-035025-index-headers.html | 0001493152-26-035025 |
| Document: 0001493152-26-035025-index.html | 0001493152-26-035025 |
| Document: 0001493152-26-035025.txt | 0001493152-26-035025 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 11w ago | EFFECT | $16.95 | awaiting T+60 | — | $1.79 (+89.44%) |
Jul 28, 2026 12w ago | 6-K | $15.04 $1.83 | ▲ +87.83% | ▲ +92.56% | $1.79 (+88.10%) |
Jul 17, 2026 14w ago | 6-K | $17.66 $3.79 | ▲ +78.54% | ▲ +83.38% | $1.79 (+89.86%) |
Jul 13, 2026 15w ago | EFFECT | $16.21 $3.79 | ▲ +76.62% | ▲ +80.61% | $1.79 (+88.96%) |
Mar 9, 2026 33w ago | EFFECT | $66.91 $18.94 | ▼ −71.69% | ▼ −83.68% | $1.79 (−97.32%) |
Feb 27, 2026 34w ago | F-1/A | $34.94 $8.85 | ▲ +74.67% | ▲ +84.00% | $1.79 (+94.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers